Literature DB >> 28888271

Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspective.

Andrew Farb1, Bram D Zuckerman2.   

Abstract

Mesh:

Year:  2017        PMID: 28888271     DOI: 10.1016/j.ahj.2017.05.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

1.  Methods for Employing Information About Uncertainty of Ascertainment of Events in Clinical Trials.

Authors:  Yiming Chen; John Lawrence; H M James Hung; Norman Stockbridge
Journal:  Ther Innov Regul Sci       Date:  2020-09-01       Impact factor: 1.778

2.  Use of Medicare Claims to Identify Adverse Clinical Outcomes After Mitral Valve Repair.

Authors:  Angela Lowenstern; Steven J Lippmann; J Matthew Brennan; Tracy Y Wang; Lesley H Curtis; Ted Feldman; Donald D Glower; Bradley G Hammill; Sreekanth Vemulapalli
Journal:  Circ Cardiovasc Interv       Date:  2019-05       Impact factor: 6.546

3.  Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Authors:  Sergio Leonardi; Anna Franzone; Raffaele Piccolo; Eugene McFadden; Pascal Vranckx; Patrick Serruys; Edouard Benit; Christoph Liebetrau; Luc Janssens; Maurizio Ferrario; Aleksander Zurakowski; Robert-Jan van Geuns; Marcello Dominici; Kurt Huber; Ton Slagboom; Paweł Buszman; Leonardo Bolognese; Carlo Tumscitz; Krzysztof Bryniarski; Adel Aminian; Mathias Vrolix; Ivo Petrov; Scot Garg; Christoph Naber; Janusz Prokopczuk; Christian Hamm; Gabriel Steg; Dik Heg; Peter Juni; Stephan Windecker; Marco Valgimigli
Journal:  BMJ Open       Date:  2019-03-09       Impact factor: 2.692

4.  Contemporary clinical management of acute pulmonary embolism: the COPE study.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Aldo Pietro Maggioni; Francesco Dentali; Andrea Fabbri; Iolanda Enea; Fulvio Pomero; Maria Pia Ruggieri; Andrea Di Lenarda; Michele Gulizia
Journal:  Intern Emerg Med       Date:  2022-01-04       Impact factor: 5.472

5.  Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.

Authors:  Mary Farrant; J Donald Easton; Eric E Adelman; Brett L Cucchiara; William G Barsan; Holly J Tillman; Jordan J Elm; Anthony S Kim; Anne S Lindblad; Yuko Y Palesch; Wenle Zhao; Keith Pauls; Kyle B Walsh; Joan Martí-Fàbregas; Richard A Bernstein; S Claiborne Johnston
Journal:  JAMA Netw Open       Date:  2019-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.